Ultrarapid Whole Genome Sequencing
Revvity Ultrarapid Whole Genome Sequencing: Get a final report for urWGS in just 5 days!
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Revvity Omics is proud to be among the first laboratories to provide whole genome sequencing as a clinical service to benefit its clients and patients. Its whole genome sequencing test offers top-quality standards and quick turnaround times. It outperforms exome sequencing tests in terms of both service and data comprehensiveness, covering over 99% of the exome. Revvity Omics' test provides industry-leading results while maintaining a competitive turnaround time.
Its comprehensive Ultrarapid Whole Genome Sequencing (urWGS) offers a range of features, including mitochondrial genome sequencing, biochemical testing, cCMV analysis, CNV detection, and more. With a turnaround time of 5 days and flexible sample types, the Revvity Omics service is a convenient and efficient option for your needs.
Redefining the genomics landscape to navigate the future of personalized medicine
Initiated by genomic testing, genomic medicine is now firmly established as a vital component of a modern healthcare system. With 80% of rare diseases having a genetic basis, genomic testing can reduce the time and number of hospital visits required to arrive at a diagnosis, improving patient experience, patient health outcomes, and total cost to the healthcare system. Genomics also plays a part in common diseases like asthma where genomic knowledge and information can assist healthcare professionals to better monitor and treat symptoms.
In this whitepaper, Revvity demonstrates how its comprehensive biochemical and genetic analysis, quick turnaround times, and ability to process large amounts of samples can aid in early intervention and management of genetic disorders in newborns.
